OLN
OLIN CorpPrice & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Net debt to adjusted EBITDA ratio non-GAAP | 5.1 | Q1 2026 | — |
|
|
|||
| Quarterly adjusted EBITDA non-GAAP | $86.2M | Q1 2026 | — |
|
|
|||
| Available under share repurchase authorizations | $1.9B | fourth quarter 2025 | — |
| Net debt | $2.7B | fourth quarter 2025 | — |
| Shares repurchased | 0.5M | fourth quarter 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OLN
this stock
OLIN Corp
|
$2.28B | -3.0% | +3.7% | — | 13.3% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$77.56B | +31.5% | — | — | 0.2% |
|
DOW
Dow Inc.
|
$19.97B | +19.9% | -7.0% | — | 4.3% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$16.78B | +31.0% | — | — | 0.0% |
|
CE
Celanese Corp
|
$5.23B | +12.8% | -7.1% | — | 6.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OLN | -6.3% | -22.2% | -10.5% | +1.1% | -3.0% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -7.7% | -21.0% | -18.5% | +1.4% | -12.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.